Osmetech Responds to FDA Update Labeling for Warfarin

Osmetech, the fast developing international molecular diagnostics business, notes yesterday’s announcement by the FDA regarding the approval of updating labelling for the widely used blood-thinning drug, Coumadin, to explain that an individual’s genetic makeup may influence how they respond to the drug.
Business Wire